Back to Journals » Journal of Inflammation Research » Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation
Journal of Inflammation Research
- View all (4115)
- Volume 19, 2026 (296)
- Volume 18, 2025 (1174)
- Volume 17, 2024 (804)
- Volume 16, 2023 (460)
- Volume 15, 2022 (493)
- Volume 14, 2021 (541)
- Volume 13, 2020 (112)
- Volume 12, 2019 (35)
- Volume 11, 2018 (47)
- Volume 10, 2017 (20)
- Volume 9, 2016 (24)
- Volume 8, 2015 (21)
- Volume 7, 2014 (17)
- Volume 6, 2013 (14)
- Volume 5, 2012 (17)
- Volume 4, 2011 (13)
- Volume 3, 2010 (15)
- Volume 2, 2009 (6)
- Volume 1, 2008 (6)
Journal Articles:
- Omics, Microbiome, and Artificial Intelligence: Novel Insights into Human Disease-Associated Inflammatory Responses (3)
- Targeting the IL-4/IL-13 Axis in the Treatment of Type 2 Inflammation (7)
- Inflammaging in Cardiovascular and Chronic Disease (4)
- Neutrophils in a New Light: Emerging Roles in Inflammation (3)
- Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation (5)
- Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases (1)
- The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation (1)
- Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes (2)
- Inflammation and brain: how inflammatory processes influence physiological and pathological functions of the central nervous system (12)
- Genetic and non-genetic inflammation networks in major human diseases (6)
- Neurodegenerative diseases: From Pathogenesis to Treatment (1)
- Unraveling the Complex Relationship Between Inflammation, Diabetes, and Obesity: A Comprehensive Exploration (2)
Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation
Chronic inflammation is the hallmark of many diseases. These conditions can be crippling to patients. Traditional anti-inflammatory drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, are non-specific, causing further systemic problems with continued use. By contrast, biologic therapies harness the specificity necessary to relieve inflammation while also reducing off-target and non-specific effects.
IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far?
Megna M, D’Agostino M, Feo F, Ventura V, Tommasino N, Potestio L
Journal of Inflammation Research 2026, 19:540848
Published Date: 10 February 2026
Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies?
Bora R, Kılıç AT, Toprak B
Journal of Inflammation Research 2025, 18:9811-9822
Published Date: 24 July 2025
Tocilizumab for Non-Infectious Uveitis: A Systematic Review
Cao H, Bian K, Ma C, Zhang N, Ma X
Journal of Inflammation Research 2025, 18:13117-13138
Published Date: 20 September 2025
Mechanisms Underlying Lichen Planus in Association with Biologic Therapy
Podolsky AS, Lipner SR
Journal of Inflammation Research 2025, 18:14961-14970
Published Date: 27 October 2025
Established and Emerging Biological Therapies for the Treatment of Comorbid Asthma and Chronic Obstructive Pulmonary Disease
Cazzola M, Matera MG, Hanania NA, Rogliani P
Journal of Inflammation Research 2025, 18:17319-17341
Published Date: 11 December 2025